Atlas Trials

Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

Clinical trial NCT07359443 · RECRUITING

Trial details

NCT number
NCT07359443
Sponsor
UMC Utrecht
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal AdenocarcinomaEsophageal Adenocarcinoma (EAC)Adenocarcinoma - Gastroesophageal Junction (GEJ)
Start date
2025-05-21
Primary completion
2028-05-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.